Another COVID-19 vaccine might soon be approved for use in the United States, an alternative that one infectious disease expert boasted as being “more traditional” than the rest.

Novavax submitted its candidate coronavirus vaccine, NVX-CoV2373, to the Food and Drug Administration on Monday for emergency use authorization for individuals 18 years or older, according to a statement.